Consilient Health is a pharmaceutical company, focused on bringing medicines that address unmet clinical needs to patients in the United Kingdom and Europe. The Company is headquartered in Ireland, with operations in UK, Sweden and additional partnerships in Europe. Our current focus is women’s health, endocrinology, bone health and urology.

In the UK our current portfolio includes a wide range of products in three main therapeutic areas: women’s health, urology and endocrinology. Within endocrinology, we have a focus on bone health with a range of prescription medicines that address vitamin D deficiency. In women’s health, Consilient Health offers a range of hormone replacement therapy (HRT treatments) that are designed to suit different women. In urology we have a medicine for bladder pain syndrome/interstitial cystitis.

We continue to focus on building our range of medicines. For more information visit www.consilienthealth.com